Abstract
In a historic first for the agency, FDA Commissioner Martin A. Makary, M.D., M.P.H., today announced an aggressive timeline to scale use of artificial intelligence (Al) internally across all FDA centers by June 30, 2025, following the completion of a new generative Al pilot for scientific reviewers.
Key Data
-
Publication Date08 May 2025
-
Primary AuthorMartin A. Makary
-
SourceFDA
-
LanguageEnglish
Click below to visit original source: